World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
82
Citations
73884
World Ranking
15832
National Ranking
7965

Overview

Catherine M. Tangen is affiliated with the Fred Hutchinson Cancer Research Center in the United States. Their research primarily focuses on areas within medicine and biochemistry, genetics, and molecular biology. The subfields covered include pulmonary and respiratory medicine, oncology, surgery, genetics, and molecular biology.

The scientist's work concentrates on topics related to cancer treatment and research, particularly involving prostate cancer, bladder and urothelial cancer treatments, genetic associations and epidemiology, renal cell carcinoma treatment, radiopharmaceutical chemistry and applications, cancer metabolism involving lipids, and studies concerning urinary and genital oncology.

Frequent coauthors collaborating with Catherine M. Tangen include:

  • Ian M. Thompson
  • Melissa Plets
  • Seth P. Lerner
  • Primo N. Lara
  • Alicja Wolk

Publications have appeared repeatedly in specific venues, reflecting key platforms for their research dissemination. These venues are:

  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • UNC Libraries
  • Nature Communications
  • European Urology

Some of the recent scientific papers authored or co-authored by the researcher include:

  • "Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis" (2020, Nature Communications)
  • "Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction" (2021, Nature Genetics)
  • "A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial" (2021, The Lancet)
  • "An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk" (2020, Nature Communications)
  • "Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk" (2020, The American Journal of Human Genetics)

Best Publications

  • Frailty in Older Adults Evidence for a Phenotype

    Linda P. Fried;Catherine M. Tangen;Jeremy Walston;Anne B. Newman

  • Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer

    Daniel P. Petrylak;Catherine M. Tangen;Maha H.A. Hussain;Primo N. Lara

  • The Influence of Finasteride on the Development of Prostate Cancer

    Ian M. Thompson;Phyllis J. Goodman;Catherine M. Tangen;M. Scott Lucia

  • Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter

    Ian M. Thompson;Donna K. Pauler;Phyllis J. Goodman;Catherine M. Tangen

  • Neoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder Cancer

    H. Barton Grossman;Ronald B. Natale;Catherine M. Tangen;V.O. Speights

  • Vitamin E and the Risk of Prostate Cancer: The Selenium and Vitamin E Cancer Prevention Trial (SELECT)

    Eric A. Klein;Ian M. Thompson;Catherine M. Tangen;John J. Crowley

  • Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update

    Ian Thompson;James Brantley Thrasher;Gunnar Aus;Arthur L. Burnett

  • Erectile Dysfunction and Subsequent Cardiovascular Disease

    Ian M. Thompson;Catherine M. Tangen;Phyllis J. Goodman;Jeffrey L. Probstfield

  • Fluorouracil plus Levamisole as Effective Adjuvant Therapy after Resection of Stage III Colon Carcinoma: A Final Report

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

  • Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial

    Ian M. Thompson;Donna Pauler Ankerst;Chen Chi;Phyllis J. Goodman

  • Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial.

    Ian M. Thompson;Catherine M. Tangen;Jorge Paradelo;M. Scott Lucia

  • Depressive Symptoms and Risks of Coronary Heart Disease and Mortality in Elderly Americans

    Abraham A. Ariyo;Mary Haan;Catherine M. Tangen;John C. Rutledge

  • Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

    Fredrick R. Schumacher;Ali Amin Al Olama;Sonja I. Berndt;Sara Benlloch

  • Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes

    Michael S. Cookson;Gunnar Aus;Arthur L. Burnett;Edith D. Canby-Hagino

  • Increased Blood Glucose and Insulin, Body Size, and Incident Colorectal Cancer

    Robert E. Schoen;Catherine M. Tangen;Lewis H. Kuller;Gregory L. Burke

  • Intermittent versus continuous androgen deprivation in prostate cancer.

    Maha Hussain;Catherine M. Tangen;Donna L. Berry;Celestia S. Higano

  • An Evaluation of the Carcinoembryonic Antigen (CEA) Test for Monitoring Patients With Resected Colon Cancer

    Charles G. Moertel;Thomas R. Fleming;John S. Macdonald;Daniel G. Haller

  • Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.

    C G Leichman;T R Fleming;F M Muggia;C M Tangen

  • Discovery of common and rare genetic risk variants for colorectal cancer

    Jeroen R. Huyghe;Stephanie A. Bien;Tabitha A. Harrison;Hyun Min Kang

Frequent Co-Authors

Ian M. Thompson
Ian M. Thompson The University of Texas Health Science Center at San Antonio
Graham G. Giles
Graham G. Giles University of Melbourne
Maha Hussain
Maha Hussain Northwestern University
Alicja Wolk
Alicja Wolk Karolinska Institute
E. David Crawford
E. David Crawford University of California, San Diego
Nicholas J. Vogelzang
Nicholas J. Vogelzang University of Nevada Reno
David E. Neal
David E. Neal University of Cambridge
Kenneth W. Muir
Kenneth W. Muir University of Manchester
David I. Quinn
David I. Quinn University of Southern California
Janet L. Stanford
Janet L. Stanford Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA opens doors to many rewarding career paths beyond becoming a doctor. For those interested in mental health, online nursing programs are evolving rapidly. You can now enroll in the fastest psychiatric nurse practitioner program to gain specialized training and qualify sooner for in-demand roles.

Healthcare is not just about patient care; leadership skills are equally vital. If you envision yourself managing medical facilities or health systems, an health care administration online degree can prepare you for high-impact administrative careers. For more advanced roles, consider the cheapest mha online programs, which are designed for flexibility and affordability.

Many professionals also advance their clinical credentials through doctoral studies. The cheapest online dnp programs help nurses expand practice authority and leadership opportunities while saving on tuition costs. These online degrees support a variety of pathways for those passionate about making a difference in healthcare.

Best Scientists Citing Catherine M. Tangen

Trending Scientists

Recently Published Articles